Several nations have committed to donating Mpox vaccines to help control the outbreak in Africa, following the World Health Organization’s (WHO) declaration of the disease as a global public health emergency for the second time in two years in August.
These donations aim to correct the significant inequity that left African nations without access to vaccines during the global outbreak in 2022.
The Democratic Republic of Congo, the epicenter of the current outbreak, initiated its first Mpox vaccination campaign on October 5.
The following countries have pledged vaccine donations, sourced from Denmark’s Bavarian Nordic or Japan’s KM Biologics:
Canada: Will provide up to 200,000 doses, with the number dependent on the receiving countries’ storage and administration capacity.
France: Plans to donate 100,000 doses, adjusted according to local needs.
Germany: Pledged 100,000 doses from its military reserves for immediate support.
Japan: Promised 3 million doses of the LC16 vaccine from KM Biologics, the largest commitment so far.
Spain: Will donate 500,000 doses, or 20% of its stockpile, and has encouraged the European Commission to urge all EU countries to follow suit.
United States: President Joe Biden pledged 1 million doses and at least $500 million in financial aid.
The U.S. has already delivered 10,000 doses to Nigeria and 50,000 doses to Congo, with an additional 300,000 ready for distribution in partnership with Gavi and WHO.
